Shilpa Medicare is amongst the leading oncology oriented pharma companies in India. Along with a strong presence in field of oncology, our other focus areas are anti-retroviral drugs along with other pharma fields presenting unmet medical needs. All our API and formulation products are supported by manufacturing facilities inspected and approved by major regulatory agencies like USFDA/WHO-GMP/ EUGMP/ TGA/ PMDA/ KFDA/ TPD.
We aim to be amongst world's leading suppliers of oncology/non-oncology APIs, intermediates and formulations. Further to consolidation in field of generic API and formulations, we are striving to put in our efforts in field of novel drug delivery systems and biotechnology along with widening our focus to other therapy areas. We ensure to provide cost reduction without compromising quality standards.